DeviceClearance

HYDRAGEL 7 LIPOPROTEIN(E), PN 4114 & HYDRAGEL LIPOPROTEIN(E) 15/30 PN 4134— 510(k) K022053

Substantially Equivalent

Sebia

FDA 510(k) clearance K022053 for HYDRAGEL 7 LIPOPROTEIN(E), PN 4114 & HYDRAGEL LIPOPROTEIN(E) 15/30 PN 4134, Substantially Equivalent on 2002-07-12. Applicant: Sebia.

Clearance details

Applicant
Sebia
Product code
Code JHO
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Chelsea, MI, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.